Zoll appointed Eric Knudsen as its new chief government officer, efficient April 1, 2026.
Knudsen will succeed Jon Rennert, who served as Zoll’s CEO for the previous 10 years and can assume a brand new position as government chairman of Zoll’s board of administrators.
“As a world chief in medical know-how, Zoll is frequently on the lookout for methods to broaden our enterprise and attain extra sufferers in want,” mentioned Rennert. “Eric has performed a novel position in creating our progress methods and driving our enlargement, and I’m assured he’ll lead Zoll to even better progress and success.”
“I’m honored to grow to be Zoll’s subsequent CEO,” mentioned Knudsen. “Zoll has a protracted legacy of innovation and scientific excellence, and right this moment our medical units, software program, and associated providers are used worldwide to diagnose and deal with sufferers affected by critical cardiopulmonary and respiratory circumstances. We are going to proceed to guide with our dedication to sufferers and clients and our ardour for enhancing outcomes and serving to save lives.”
Knudsen has practically 30 years of expertise within the medtech trade, with deep experience in enterprise growth and company technique. He led Zoll’s Company Growth crew for six years and was chargeable for investing in strategic relationships and buying greater than a dozen new applied sciences.
For the previous 4 years, Knudsen was President of Zoll Itamar, a division of Zoll that’s centered on the analysis of sleep issues. Knudsen led the division via vital progress and a dramatic enhance in profitability.
Previous to becoming a member of Zoll in 2013, Knudsen held management positions in worldwide gross sales, advertising and marketing, and manufacturing partnerships at Covidien (now Medtronic), Side Medical Techniques, and LeMaitre Vascular. He has an MBA from the Thunderbird College of International Administration and a bachelor’s diploma from Boston Faculty.
Rennert was named CEO of Zoll in 2016, after serving as President of the corporate’s largest enterprise unit for eight years. Underneath Rennert’s management as CEO, Zoll expanded its attain as a world chief in exterior defibrillation, pioneered novel options for sufferers with critical cardiopulmonary and respiratory circumstances, and considerably broadened its portfolio of merchandise.
